603 filings
Page 10 of 31
8-K
xtagjq
26 Feb 21
Immunic, Inc. Reports Year End 2020 Financial Results and Highlights Recent Activity
6:53am
SC 13G
wghebp1v
19 Feb 21
IMMUNIC / Oetker Roland ownership change
6:30am
8-K
oeov0h59hruka7
18 Feb 21
Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial
7:40am
SC 13G/A
44ag473eqb
16 Feb 21
IMMUNIC / Artal International S.C.A. ownership change
12:00am
SC 13G/A
qorl3r0h5 7ylvlhck
12 Feb 21
IMMUNIC / Altium Capital Management ownership change
12:47pm
SC 13G
0k4ieklicg8
8 Feb 21
IMMUNIC / FMR ownership change
10:25am
8-K
wkqlnbyn8y8 jrt2
4 Jan 21
Entry into a Material Definitive Agreement
6:03am
424B5
8r0k6hr
29 Dec 20
Prospectus supplement for primary offering
4:31pm
EFFECT
1trnui8u 6omgu4uar
25 Nov 20
Notice of effectiveness
12:15am
UPLOAD
effyhnnq08shs9dg
20 Nov 20
Letter from SEC
12:00am
CORRESP
pixsng0of80zfmvj0
20 Nov 20
Correspondence with SEC
12:00am
8-K/A
fx90r 2snxz
13 Nov 20
Entry into a Material Definitive Agreement
4:10pm
424B5
81d6a6px6 kqfzaf
12 Nov 20
Prospectus supplement for primary offering
6:01am
8-K
ar2e 67kd
5 Nov 20
Immunic, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:09pm
4
w0a neeivf
22 Oct 20
IMMUNIC / Duane Nash ownership change
7:40pm
8-K
unfjdl r4prv
20 Oct 20
EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
7:19am
SC 13D/A
m8fiug j1w84q4rf
21 Sep 20
IMMUNIC / Eckenstein-Geigy-Stiftung ownership change
4:05pm
8-K
8mmy8
11 Sep 20
Regulation FD Disclosure
8:01am